Skip to main content

Volume 15 Supplement 17

Intravenous versus subcutaneous application of biotherapeutics in IBD: an expert’s and patient's perspective

Proceedings

Publication of this supplement has been funded by Takeda. The article has undergone the journal's standard peer review process for supplements. The Supplement Editor declares no competing interests.

Virtual21 January - 2 February 2021

  1. Several biologic treatments are available in addition to intravenous also in subcutaneous form for treatment of chronic diseases. Benefits of the subcutaneous application of drugs include self-administration b...

    Authors: Laimas Jonaitis, Srdjan Marković, Klaudia Farkas, Liana Gheorghe, Željko Krznarić, Riina Salupere, Viktorija Mokricka, Zoya Spassova, Dimo Gatev, Isabella Grosu, Anton Lijović, Olga Mitrović, Mateja Saje, Eszter Schafer, Viktor Uršič, Tina Roblek…
    Citation: BMC Proceedings 2021 15(Suppl 17):25

Annual Journal Metrics

  • Speed
    40 days from acceptance to publication

    Citation Impact
    3.100 - Cite Score
    0.693 - Source Normalized Impact per Paper (SNIP)
    0.790 - SCImago Journal Rank (SJR)

    Usage
    738,709 downloads (2021)
    53 Altmetric mentions